(Q56774001)

English

Neuropsychiatric effects of Parkinson's disease treatment

scholarly article by Sallyanne Aarons et al published September 2012 in Australasian Journal on Ageing

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Neuropsychiatric effects of Parkinson's disease treatment (English)

0 references

1 reference

2

Carmelle Peisah

0 references

author name string

Sallyanne Aarons

series ordinal

1

0 references

Chanaka Wijeratne

series ordinal

3

0 references

language of work or name

English

0 references

publication date

September 2012

0 references

published in

Australasian Journal on Ageing

0 references

volume

31

0 references

issue

3

0 references

page(s)

198-202

0 references

cites work

Psychosis and Other Psychiatric Manifestations of Levodopa Therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Recognition and management of neuropsychiatric complications in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Early dopaminergic drug-induced hallucinations in parkinsonian patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Atypical antipsychotic drugs in the treatment of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Dopamine-induced nonmotor symptoms of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Deep brain stimulation for Parkinson's disease: where do we stand?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Dopamine agonist withdrawal syndrome in Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Pramipexole, ropinirole, and mania in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1741-6612.2012.00632.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1741-6612.2012.00632.X

0 references

PubMed publication ID

22950594

0 references

(Q56774001)

Neuropsychiatric effects of Parkinson's disease treatment

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)